Lisa Mary Raven (Lisa M Raven)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Left Ventricular

Glycemic Control

Top Venues

Acta diabetologica

JCEM case reports

Diabetic medicine : a journal of the British Diabetic Association

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Mary Raven, Louise Goodall, Jacqueline R Center, Christopher A Muir
Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients. JCEM case reports 2 (3) (2024)
Lisa Mary Raven, Louise Goodall, Jacqueline R Center, Christopher A Muir
Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients. JCEM case reports 2 (3) (2024)
Annabelle G Hayes, Lisa Mary Raven, Alexander Viardot, Eugene Kotlyar, Jerry R Greenfield
SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes. Diabetes care (2023)
Lisa Mary Raven, Christopher A Muir, Cassia Kessler Iglesias, Nicole K Bart, Kavitha Muthiah, Eugene Kotlyar, Peter Macdonald, Christopher S Hayward, Andrew Jabbour, Jerry R Greenfield
Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial. BMJ open 13 (3) (2023)
Lisa Mary Raven, Campbell Brown, Jerry R Greenfield
Considerations of delayed gastric emptying with peri-operative use of glucagon-like peptide-1 receptor agonists. The Medical journal of Australia (2023)
Lisa Mary Raven, Christopher A Muir, Cassia Kessler Iglesias, Nicole K Bart, Kavitha Muthiah, Eugene Kotlyar, Peter Macdonald, Christopher S Hayward, Andrew Jabbour, Jerry R Greenfield
Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial. BMJ open 13 (3) (2023)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica (2022)
Lisa Mary Raven, Penny Morris, Jerry R Greenfield
Hyperglycaemia induced by gamma-butyrolactone. Diabetic medicine : a journal of the British Diabetic Association 39 (8) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica 60 (4) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica 60 (4) (2022)
Lisa Mary Raven, Jerry R Greenfield, Christopher A Muir
Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes. JCEM case reports 1 (1) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica 60 (4) (2022)